Pharma major Dr Reddy’s Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. IMAGE: Satish......
The broader market performance, however, is expected to be better by virtue of good performance of state-owned banks on a low base. Nearly one-third of Sensex 30 companies are likely to report a......
Tata Consultancy Services (TCS), the country’s largest player in information-technology (IT) export, has seen a sharp decline in its contribution to the Tata group’s market......
While the positive surprise has been the high growth in agriculture, the negative surprise is in the trade, transport, hotels segment where growth came lower than expected, says Madan Sabnavis.......
This is despite the fact that total FDI into India has fallen by 22 per cent from $58 billion in FY22 to $46 billion in FY23. Illustration: Dominic Xavier/Rediff.com India's share gain of foreign......